Sex differences in arrhythmias

Current Opinion in Cardiology

Volumn 25, Issue 1, 2010, Pages 8-15

  Rivero, Abel ^a   Curtis, Anne B ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Arrhythmia; Electrophysiology; Sex differences

Indexed keywords

ANTIARRHYTHMIC AGENT; CYTOCHROME P450; ESTROGEN; SEX HORMONE; TESTOSTERONE;

ALLELE; BRUGADA SYNDROME; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; DEFIBRILLATOR; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HEART ARREST; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; INHERITANCE; LONG QT SYNDROME; MALE; NONHUMAN; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; TORSADE DES POINTES;

ALLELES; ARRHYTHMIAS, CARDIAC; CARDIAC PACING, ARTIFICIAL; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; LONG QT SYNDROME; MALE; SEX FACTORS; TREATMENT OUTCOME;

EID: 74249089741     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328333f95f     Document Type: Review

References (63)

1. Liu S, Yuan S, Kongstad O, Olsson SB. Gender differences in the electrophysiological characteristics of atrioventricular conduction system and their clinical implications. Scan Cardiovasc J 2001; 35:313-317.
2. Liuba I, Jönsson A, Säfström K, Walfridsson H. Gender-related differences in patients with atrioventricular nodal reentry tachycardia. Am J Cardiol 2006; 97:384-388.
3. Rodriguez LM, deChillou C, Schlapfer J, et al. Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol 1992; 70:1213-1215.
4. Calkins H, Yong P, Miller JM, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter trial. Circulation 1999; 99:262-270.
5. Rosano GMC, Leonardo F, Sarrei PM, et al. Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet 1996; 347:786-788.
6. Myerburg RJ, Cox MM, Interian A, et al. Cycling of inducibility of paroxysmal supraventricular tachycardia in women and its implications for timing of electrophysiology procedures. Am J Cardiol 1999; 83:1049-1054.
7. Krahn AD, Yee R, Klein GJ, et al. Inappropriate sinus tachycardia: evaluation and therapy. J Cardiovasc Electrophysiol 1995; 6:1124-1128.
8. Chiale PA, Garro HA, Schmidberg J, et al. Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta adrenergic receptors. Heart Rhythm 2006; 3:1182-1186.
9. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart study. JAMA 1994; 271:840-844.
10. Cooklin M, Gold MR. Implications and treatment of atrial fibrillation after cardiothoracic surgery. Curr Opin Cardiol 1998; 13:20-27.
11. Chen LY, Herron KJ, Tai BC, Olson TM. Lone atrial fibrillation: influence of familial disease on gender predilection. J Cardiovasc Electrophysiol 2008; 19:802-806.
12. Lai J, Zhou D, Xia S, et al. Reduced testosterone levels in males with lone atrial fibrillation. Clin Cardiol 2009; 32:43-46.
13. Hnatkova K, Walstare JEP, Murgatroyd FD. Age and gender influences on rate and duration of paroxysmal atrial fibrillation. PACE 1998; 21:2455-2458.
14. Cabin HS, Clubb S, Hall C. Risk of systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol 1990; 65:1112-1116.
15. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart study. Circulation 1998; 98:946-952.
16. Dagres N, Nieuwlaat R, Vardas P, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe. J Am Coll Cardiol 2007; 49:572-577.
17. Yarnoz MJ, Curtis AB. More reasons why men and women are not the same (gender differences in electrophysiology and arrhythmias). Am J Cardiol 2008; 101:1291-1296.
18. Wyse DG, Waldo AL, DiMarco JP, et al. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347:1825-1833.
19. Essebag V, Reynolds MR, Hadjis T, et al. Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med 2007; 167:1648-1653.
20. Forleo GB, Tondo C, De Luca L, et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace 2007; 9:613-620. (Pubitemid 47263791)
21. Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993; 270:2590-2597.
22. Goldenberg I, Zareba W, Moss AJ. Long QT syndrome. Curr Probl Cardiol 2008; 33:629-694.
23. Locati EH, Zareba W, Moss AJ, et al. Age and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS registry. Circulation 1998; 97:2237-2244.
24. Zareba W, Moss AJ, Locati EH, et al. International Long QT Syndrome Registry. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. J Am Coll Cardiol 2003; 42:103-109.
25. Goldenberg I, Moss AJ, Peterson DR, et al. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation 2008; 117:2184-2191.
26. Hobbs JB, Peterson DR, Moss AJ, et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA 2006; 296:1249-1254.
27. Sauer AJ, Moss AJ, McNitt S, et al. Long QT syndrome in adults. J Am Coll Cardiol 2007; 49:329-337.
28. Goldenberg I, Moss AJ, Bradley J, et al. Long-QT syndrome after age 40. Circulation 2008; 117:2192-2201.
29. Bidoggia H, Maciel JP, Capalozza N, et al. Sex differences on the electrocardiographic pattern of cardiac repolarization: possible role of testosterone. Am Heart J 2000; 140:678-683.
30. Stolt A, Karila T, Viitasalo M, et al. QT interval and QT dispersion in endurance athletes and in power athletes using large doses of anabolic steroids. Am J Cardiol 1999; 84:364-366; A9.
31. Larsen JA, Tung RH, Sadananda R, et al. Effects of hormone replacement therapy on QT interval. Am J Cardiol 1998; 82:993-995.
32. Imboden M, Swan H, Denjoy I, et al. Female predominance and transmission distortion in the long-QT syndrome. N Engl J Med 2006; 355:2744-2751.
33. Kurokawa J. Compartmentalized regulations of ion channels in the heart. Biol Pharm Bull 2007; 30:2231-2237.
34. Bai CX, Kurokawa J, Tamagawa M, et al. Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 2005; 112: 1701-1710.
35. Furukawa T, Kurokawa J. Regulation of cardiac ion channels via nongenomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias. Pharmacol Ther 2007; 115:106-115.
36. Hreiche R, Morissette P, Turgeon J. Drug-induced long QT syndrome in women: review of current evidence and remaining gaps. Gend Med 2008; 5:124-135.
37. Kannel WB, Wilson PWF, D'Agostino RB, et al. Sudden coronary death in women. Am Heart J 1998; 136:205-212.
38. Albert CM, McGovern BA, Newell JB, et al. Sex differences in cardiac arrest survivors. Circulation 1996; 93:1170-1176.
39. Wigginton JG, Pepe PE, Bedolla JP, et al. Sex-related differences in the presentation and outcome of out-of-hospital cardiopulmonary arrest: a multiyear, prospective, population-base study. Crit Care Med 2002; 30 (4 Suppl): S131-S136.
40. Yap YG, Duong T, Bland M, et al. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicenter trials. Eur Heart J 2005; 26:1385-1393. (Pubitemid 41373515)
41. Lujan HL, Kramer VJ, DiCarlo SE. Sex influences the susceptibility to reperfusion- induced sustained ventricular tachycardia and beta-adrenergic receptor blockade in conscious rats. Am J Physiol Heart Circ Physiol 2007; 293: H2799-H2808.
42. Lujan HL, Dicarlo SE. Sex differences to myocardial ischemia and betaadrenergic receptor blockade in conscious rats. Am J Physiol Heart Circ Physiol 2008; 294:H1523-H1529.
43. Haigney MC, Zareba W, Nasir JM, et al., MADIT II Investigators. Gender differences and risk of ventricular tachycardia or ventricular fibrillation. Heart Rhythm 2009; 6:180-186.
44. Sarkozy A, Brugada P. Sudden cardiac death and inherited arrhythmia syndromes. J Cardiovasc Electrophysiol 2005; 16:S8-S20. (Pubitemid 44914764)
45. Benito B, Sarkozy A, Mont L, et al. Gender differences in clinical manifestations of Brugada syndrome. J Am Coll Cardiol 2008; 52:1567-1573.
46. Heart disease and stroke statistics. 2005 update. American Heart Association, p. 10.
47. Russo AM, Stamato NJ, Lehmann MH, et al., for the MUSTT Investigators. Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial. J Cardiovasc Electrophysiol 2004; 15:993-998.
48. Zareba W, Moss AJ, Hall WJ, et al. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol 2005; 16:1265-1270.
49. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-1583.
50. Lampert R, McPherson CA, Clancy JF, et al. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. J Am Coll Cardiol 2004; 43:2293-2299.
51. Kudenchuk PJ, Bardy GH, Poole JE, et al. Malignant sustained ventricular tachyarrhythmias in women: characteristics and outcome of treatment with an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 1997; 8:2-10.
52. Hernandez AF, Fonarow GC, Liang L, et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA 2007; 298:1525-1532.
53. Curtis LH, Al-Khatib SM, Shea AM, et al. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA 2007; 298:1517-1524.
54. Peterson PN, Daugherty SL, Wang Y, et al., National Cardiovascular Data Registry. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation 2009; 119:1078-1084.
55. Heart disease and stroke statistics. 2005 update. American Heart Association, p. 26.
56. Heart disease and stroke statistics. 2005 update. American Heart Association, p. 27.
57. Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289:194-202.
58. Bleeker GB, Schalij MJ, Boersma E, et al. Does a gender difference in response to cardiac resynchronization therapy exist? PACE 2005; 28: 1271-1275.
59. Bristow MR, Saxon LA, Boehmer J, et al., Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350:2140-2150.
60. Cleland JG, Daubert JC, Erdmann E, et al., Cardiac Resynchronization- Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549.
61. Woo GW, Petersen-Stejskal S, Johnson JW, et al. Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study. J Interv Card Electrophysiol 2005; 12:107-113.
62. Markowitz SM, Lewen JM, Wiggenhorn CJ, et al. Relationship of reverse anatomical remodeling and ventricular arrhythmias after cardiac resynchronization. J Cardiovasc Electrophysiol 2009; 20:293-298.
63. Yarnoz MJ, Curtis AB. Sex-based differences in cardiac resynchronization therapy and implantable cardioverter-defibrillator therapies: effectiveness and use. Cardiol Rev 2006; 14:292-298.